KLK3 and prostate carcinoma: In prostate cancer, hypoxia activates the transcription factor androgen receptor (AR) by increasing the binding between AR and androgen responsive elements (AREs), which induces the expression of its target gene, prostate-specific antigen (PSA), and thereby regulating tumor progression [81].